This association between thissignature and IDH mutations appears to be particular to CCA,since it was not observed upon analysis of TCGA datasets for glioblastoma,low-grade glioma, melanoma, or acute myeloid leukemia TCGA datasets (Figure S3C). This evidence concerns the gene IDH1 and central nervous system cancer.